tadalafil dosage - viagra - augmentin uses - http://sildenafilgeneric-citrate.com/ - levitra 20mg vs viagra 100mg - furosemide for dogs - lisinopril hctz - cialis generic - gabapentin 300mg - doxycycline hyclate 100mg

Posts Tagged 'Phase III Trials'

Nuvilex, Inc. Could Become Significant Player in the Oncology Arena with Successful Phase III Trials

Nuvilex, Inc. Could Become Significant Player in the Oncology Arena with Successful Phase III Trials

Written by ι Stock Market Media Group Staff — May 22, 2013

Nuvilex, Inc. (OTCQB NVLX) is a diamond in the rough in the truest sense.  Currently shares of the Silver Spring, Maryland, biotechnology firm can be purchased for around 0.15/share allowing investors to build an incredible position in the company for what could be a blockbuster future.  Don’t expect these great prices to last forever though.  According to Nuvilex’s COO, Dr. Gerry Crabtree, the company expects to start its pivotal Phase III ...

Read More →
0

Nuvilex, Inc. and Celgene Corp. Can Both Replace Eli Lilly’s Cancer Drug Gemzar

Nuvilex, Inc. and Celgene Corp. Can Both Replace Eli Lilly’s Cancer Drug Gemzar

Written by ι Stock Market Media Group Staff — May 20, 2013

The race is on, and patients with advanced stage, inoperable pancreatic cancer will be the recipients of the winner’s treatment.  Two biotechnology companies are registering impressive data in each of their own pancreatic cancer trials, so impressive in fact, Eli Lilly & Co. (NYSE: LLY) is surely feeling its long time reign as the current standard single-drug treatment for the disease being threatened.  Nuvilex, Inc. (OTCQB: NVLX) and Celgene Corp. (NASDAQ: ...

Read More →
0

Nuvilex, Inc. COO Discusses Upcoming Phase III Pancreatic Cancer Trials

Nuvilex, Inc. COO Discusses Upcoming Phase III Pancreatic Cancer Trials

Dr. Gerald Crabtree Addresses Study Sites, Seeking Fast Track & Orphan Drug Status and More

Written by ι Stock Market Media Group Staff — May 13, 2013

Nuvilex, Inc. (OTCQB: NVLX) COO Dr. Gerald Crabtree is no stranger to late stage clinical trials or dealing with blockbuster therapies for cancer patients.  It’s likely that is exactly why he’s the COO at the small Silver Spring, Maryland, biotech.  The road that Nuvilex is currently on – preparing for a large scale Phase III clinical trial ...

Read More →
0
ContactUs.com